Related Experiment Video

Updated: Sep 23, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

[A new view on p53 protein cytoplasmic sequestration]

Sétha Douc-Rasy1, Jean Bénard

  • 1Institut Gustave-Roussy, UMR-CNRS8126, Département de biologie, Unité des marqueurs génétiques des cancers, Villejuif.

Bulletin Du Cancer
|July 19, 2003
PubMed

Insights

p53 protein inactivation in tumors can occur via cytoplasmic sequestration. A newly identified protein, Parc, anchors p53 outside the nucleus, but its inhibition restores p53 function and cancer cell sensitivity to therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • p53 protein, a tumor suppressor, is frequently inactivated in human cancers.
  • Mechanisms of p53 inactivation include mutation and cytoplasmic sequestration.
  • Neuroblastoma serves as a model for studying p53 cytoplasmic sequestration.

Purpose:

  • To investigate the molecular mechanisms of p53 cytoplasmic sequestration.
  • To identify proteins involved in anchoring p53 in the cytoplasm.
  • To explore therapeutic strategies targeting p53 sequestration.

Summary:

  • Researchers identified a cytoplasmic protein, Parc, that binds to wild-type p53 (wt p53) and sequesters it in the cytoplasm.
  • This sequestration prevents wt p53 from performing its nuclear functions, contributing to tumor development.
  • Using anti-Parc siRNA, p53 was successfully relocated to the nucleus, restoring its function and enhancing chemo-radiosensitivity in neuroblastoma cells.

Impact:

  • This study reveals Parc as a key player in p53 inactivation via cytoplasmic sequestration.
  • Targeting Parc offers a potential therapeutic strategy to restore p53 tumor-suppressive activity.
  • The findings may lead to novel treatments for neuroblastoma and other cancers with p53 inactivation.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...